Skip to main content

X4 Pharmaceuticals, INC

Boston, MA
United States

TAP Partner

X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company and a leader in the discovery and development of novel therapies for the treatment of diseases resulting from dysfunction of the CXCR4 pathway, with a focus on rare diseases and those with limited treatment options.

Program Name(s)
Therapy Acceleration Program
X4 Pharmaceuticals